Element Nutritional Sciences Inc (TSE:MUSL) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Promino Nutritional Sciences Inc. has initiated a preclinical trial led by Dr. Patrick Gunning to test the effectiveness of its Promino™ product in preserving muscle mass for cancer patients during intense chemotherapy. If successful, the company plans to develop a specialized version for the North American healthcare market. Additionally, Promino has recently achieved milestones in retail partnerships, production, and clinical results, underscoring its growing presence in the nutritional supplement industry.
For further insights into TSE:MUSL stock, check out TipRanks’ Stock Analysis page.